Weight Loss Pills - Search News

News

1st Weight-Loss Pill From Lilly Shows Promising Results

New York Post · 2d

Everything to know about the new weight loss pill that works as well as Ozempic — and when you can get it

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

Fox Business on MSN · 1d

Weight-loss drugs entering 'new era' with breakthrough daily pill

Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets in 2026. It reportedly works as well as Ozempic.

U.S. News & World Report · 2d

First Weight-Loss Pill From Lilly Shows Promising Results

Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose weight. The company is hoping to bring the first GLP-1 weight-loss pill to market, The Wall Street Journal said.

2don MSN

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

16hon MSN

Are weight loss supplements useless? Nutrition coach reveals truth

Weight loss supplements, when not backed with a healthy diet and strength training, can have side-effects on the body.

Mom and More on MSN1d

PhenQ Reviews (2025) Does It Really Support Healthy Weight Loss? Exploring The Science Behind The Hype!

PhenQ is a recently launched weight loss supplement for women that has been garnering rave reviews in the market over ...

The Manila Times1d

Best Fat Burner Pills in Canada: Top Weight Loss Supplements for Canadians in 2025 (By PhenQ CA)

PhenQ is the number 1 fat burner in Canada for many reasons. This unique product is a powerful weight loss supplement that ...

FOX 32 Chicago6d

Pfizer ends development of pill to treat obesity after injury reported during trial

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results